Image

Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Study of Relacorilant with Nab-Paclitaxel and Gemcitabine for advanced pancreatic cancer.

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study looks at using a new medicine, relacorilant, with two existing cancer drugs, nab-paclitaxel and gemcitabine, to treat metastatic pancreatic adenocarcinoma (PDAC). PDAC is a type of cancer in the pancreas that has spread to other parts of the body. The study is in two parts. In the first part, researchers will find the best dose of relacorilant by trying different amounts on around 6 patients. In the second part, the best dose found will be given to more patients to see how well it works.

  • This study requires taking medicine by mouth and receiving treatments with nab-paclitaxel and gemcitabine.
  • Participants must have no previous chemotherapy for metastatic PDAC and meet specific health criteria.
  • Patients should expect multiple visits and evaluations to track safety and effectiveness.
Print
Study details
    Adenocarcinoma
    Carcinoma
    Pancreatic Ductal

NCT07259317

Corcept Therapeutics

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.